INSILENS, A Noetera Company

Biotech Intelligence Platform

Turn Global Biotech Signals, Into Strategic Intelligence

Explore with us

Biotech Signals. Structured for Decisions.

INSILENS converts global biotech activity into decision-grade intelligence for investors, executives, and business development teams.

Deals and Financing
Therapeutic Indication
Technology Modalities
View all

Weekly Market Insight

Takeda – Rusfertide US Rights Deal
Zynlonta Safety Concerns Raise Regulatory Risk
Fortress Biotech, $205M Priority Review Voucher Sale
CellCentric – $220M Financing for Inobrodib